Market: KOSPI (000660)
Brokerage : Hana Securities
Analyst : Rok-ho Kim, Young-gyu Kim
Investment Rating : BUY (Maintained)
Target Price : KRW 240,000 (Maintained)
Core Momentum : Official disclosure of the 2025–2027 shareholder return policy increases the fixed annual dividend to KRW 1,500 while redirecting previous annual 5% FCF payouts toward strengthening financial health, setting the stage for medium-to-long term valuation re-rating as historical financial discounts against global peers are resolved.
📊 1. [Valuation & Key Financial Metrics]
- Stock Price & Target Price: Current Price (11.27) KRW 168,300, Target Price (12M) KRW 240,000, Investment Rating BUY (Maintained)
- Market Cap & Supply Metrics: Market Capitalization KRW 122.523 trillion, Total Shares Outstanding 728.002 million shares, Foreign Ownership 54.43%
- Key Financial Projections (Hana Securities Estimates):
- 2024F Revenue: KRW 66.255 trillion, Operating Profit: KRW 23.294 trillion, Net Income: KRW 17.384 trillion (EPS: KRW 23,879, Turned to Profit)
- 2025F Revenue: KRW 90.529 trillion, Operating Profit: KRW 37.754 trillion, Net Income: KRW 28.881 trillion (EPS: KRW 39,671)
- Valuation & Financial Metrics:
- 2024F: P/E 7.05x, P/B 1.69x, EV/EBITDA 3.92x, ROE 28.14%
- 2025F: P/E 4.24x, P/B 1.22x, EV/EBITDA 2.25x, ROE 34.35%
- Note: The data table lists 2024F/2025F DPS at KRW 1,200; however, per the newly disclosed policy, the fixed annual dividend is set to increase to KRW 1,500 starting in 2025.
🚀 2. [Market Opportunities & Business Outlook]
- 2025–2027 Shareholder Return Policy: The annual fixed dividend is raised from KRW 1,200 to KRW 1,500. The former annual 5% FCF supplemental dividend is eliminated and redirected to strengthen balance sheet soundness. After the 3-year policy period concludes, additional shareholder returns will be determined based on residual funds within the cap of 50% cumulative 3-year FCF, with early supplemental returns possible if financial soundness targets are met ahead of schedule.
- Corporate Value Enhancement Plan: CapEx is targeted at the mid-30% range of revenue on a 3-year moving average basis. Driven by HBM leadership, investment will focus strictly on securing timely technological competitiveness rather than volume expansion alone.
- Valuation Re-rating via Financial Health: While near-term market sentiment may reflect slight disappointment regarding the deferred annual FCF payouts, accumulating 3-year cumulative FCF to bolster financial soundness before returning capital is a rational move given memory cyclicality. Improving financial metrics relative to top-tier global peers addresses historical balance sheet discounts and justifies medium-to-long term valuation premiums.
📝 Editor’s Comment (Perspective)
The analyst evaluates SK hynix’s 2025–2027 shareholder return framework as a rational strategic pivot prioritizing structural balance sheet reinforcement and higher fixed dividends (KRW 1,500) over near-term annual supplemental payouts. Recognizing the volatile nature of the memory market, the perspective emphasizes that allocating capital toward timely technological advancements (CapEx at mid-30% of revenue) while conditioning additional returns on post-period residual funds within 50% cumulative FCF will resolve historical financial discounts against global peers and drive sustained valuation re-rating.
To determine whether this investment thesis is actually playing out, investors should closely monitor the steady distribution of the KRW 1,500 annual fixed dividend, disciplined CapEx execution within the mid-30% revenue envelope to maintain HBM leadership, and the pace of net debt reduction leading to early achievement of financial soundness targets. These operational milestones can be verified through upcoming quarterly earnings releases and periodic regulatory filings.
📢 Disclaimer & Source
Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.
Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)
